Anti-NMDA receptor encephalitis: A neurological and psychiatric emergency;Anti-NMDA-Rezeptor-Enzephalitis: Ein neurologisch-psychiatrischer Notfall

Fortschritte der Neurologie Psychiatrie

Volumn 80, Issue 1, 2012, Pages 29-35

  Pedrosa, David José ^a   Geyer, C ^a   Klosterkotter J ^a   Fink, G R ^a   Burghaus, L ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

acute psychosis; affective disorder; anti NMDA receptor encephalitis; epilepsy

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; ASSISTED VENTILATION; AUTONOMIC DYSFUNCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DISEASE COURSE; DYSKINESIA; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; GYNECOLOGY; HALLUCINATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE; NEOPLASM; NEUROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; OUTCOME ASSESSMENT; PARANOIA; PHYSICIAN; PROGNOSIS; PSYCHIATRIST; PSYCHOSIS; SEIZURE; TERATOMA; THERAPY DELAY; TREATMENT DURATION;

ADULT; AUTOIMMUNE DISEASES; AUTONOMIC NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; DYSKINESIAS; ELECTROENCEPHALOGRAPHY; EMERGENCY MEDICAL SERVICES; EPILEPSY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGY; PSYCHIATRY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84855765412     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0031-1281961     Document Type: Article

References (26)

1. Dalmau J, Tzn E, Wu HY et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol: 2007; 61 25 36 (Pubitemid 46214241)
2. Dalmau J, Lancaster E, Martinez-Hernandez E et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol: 2011; 10 63 74
3. Granerod J, Ambrose HE, Davies NW et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis: 2010; 10 835 844
4. Graus F, Delattre JY, Antoine JC et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry: 2004; 75 1135 1140 (Pubitemid 39005770)
5. Gultekin SH, Rosenfeld MR, Voltz R et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain: 2000; 123 1481 1494 (Pubitemid 30420947)
6. Voltz R, Gultekin SH, Rosenfeld MR et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med: 1999; 340 1788 1795 (Pubitemid 29266402)
7. Dalmau J, Gleichman AJ, Hughes EG et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol: 2008; 7 1091 1098
8. Hughes EG, Peng X, Gleichman AJ et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci: 2010; 30 5866 5875
9. Pruss H, Dalmau J, Harms L et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology: 2010; 75 1735 1739
10. Tzn E, Zhou L, Baehring JM et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol: 2009; 118 737 743
11. Bernal F, Graus F, Pifarr A et al. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol: 2002; 103 509 515 (Pubitemid 36075348)
12. Blumenthal DT, Salzman KL, Digre KB et al. Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology: 2006; 67 146 149 (Pubitemid 44305481)
13. Dalmau J, Gultekin SH, Voltz R et al. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain: 1999; 122 27 39 (Pubitemid 29046270)
14. Chartoff EH, Heusner CL, Palmiter RD. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology: 2005; 30 1324 1333 (Pubitemid 40848086)
15. Haggerty GC, Forney RB, Johnson JM. The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period. Toxicol Appl Pharmacol: 1984; 75 444 453 (Pubitemid 14017214)
16. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology: 1999; 20 201 225 (Pubitemid 29067401)
17. Mouri A, Noda Y, Noda A et al. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mol Pharmacol: 2007; 71 1598 1609 (Pubitemid 47010913)
18. Weiner AL, Vieira L, McKay CA et al. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med: 2000; 18 447 451 (Pubitemid 30236411)
19. Irani SR, Bera K, Waters P et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain: 2010; 133 06 1655 1667
20. Prss H, Dalmau J, Arolt V et al. Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture. Nervenarzt: 2010; 81 396, 398, 400, passim
21. Wandinger KP, Saschenbrecker S, Stoecker W et al. Anti-NMDA-receptor encephalitis: A severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol: 2011; 231 86 91
22. Day GS, High SM, Cot B et al. Anti-NMDA-Receptor Encephalitis: Case Report and Literature Review of an Under-Recognized Condition. J Gen Intern Med: 2011; 26 811 816
23. Kommission Leitlinien der Deutschen Gesellschaft fr Neurologie Chronische immunvermittelte ZNS-Erkrankungen. In: Diener HC, Putzki N. Leitlinien fr die Diagnostik und Therapie in der Neurologie. 4. berarb. Aufl Stuttgart Thieme: 2008; 384 391
24. Iizuka T, Sakai F, Ide T et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology: 2008; 70 504 511 (Pubitemid 351653374)
25. Ishiura H, Matsuda S, Higashihara M et al. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology: 2008; 71 1921 1923
26. Davies G, Irani SR, Coltart C et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med: 2010; 38 679 682